---
schema_version: "secwatch.filing_event.v1"
accession: "0001653477-25-000005"
form_type: "8-K"
ticker: "NGVT"
cik: "0001653477"
company_name: "Ingevity Corp"
filed_at: "2025-01-16T23:59:59+00:00"
generated_at: "2026-05-28T00:06:52.980621+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Ingevity explores sale of Industrial Specialties line; prelim FY2024 sales $1.40B, EBITDA ~$360M

## Summary
- Exploring strategic alternatives for Performance Chemicals Industrial Specialties product line, including potential divestiture of North Charleston CTO refinery.
- Preliminary FY2024 net sales ~$1.40B; Adjusted EBITDA ~$360M (high end of prior guidance); free cash flow >$40M (significantly above guidance).
- 2025 Adjusted EBITDA expected slightly above $400M, excluding any impact from strategic alternatives review.
- Management evaluating additional actions to maximize shareholder value; sequential segment EBITDA margin improvement in H2 2024.

## SEC filing metadata
- accession: 0001653477-25-000005
- form_type: 8-K
- ticker: NGVT
- cik: 0001653477
- company_name: Ingevity Corp
- filed_at: 2025-01-16T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1653477/000165347725000005/0001653477-25-000005-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1653477/000165347725000005/ngvt-20250116.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001653477-25-000005
- JSON: https://secwatch.observer/filing/0001653477-25-000005.json
- Plain text: https://secwatch.observer/filing/0001653477-25-000005.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.